Risk factors for severe respiratory syncytial virus-associated lower respiratory tract infection in children

被引:25
作者
Kaneko, M
Watanabe, J
Ueno, E
Hida, M
Sone, T
机构
[1] Shizuoka Red Cross Hosp, Dept Pediat, Shizuoka 4200853, Japan
[2] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan
[3] Minist Hlth Welf, Natl Publ Hlth Inst, Dept Publ Hlth Adm, Tokyo, Japan
关键词
early infant; lower respiratory tract infection; respiratory syncytial virus; risk factor;
D O I
10.1046/j.1442-200X.2001.01438.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Respiratory syncytial virus (RSV) is the most important cause of viral lower respiratory tract infection that can be a life-threatening disease in infants and children. This study was conducted to look for independent risk factors for severe respiratory syncytial virus-associated lower respiratory tract infection (RSV-LRI) that required oxygen supplementation or mechanical ventilation. Methods: Medical records of patients younger than 4 years hospitalized with RSV-LRI at Shizuoka Red Cross Hospital from July 1, 1995 to June 30, 1999 were reviewed. The patients were compared using univariate and multivariate logistic regression analysis. Results: A total of 157 patients were hospitalized with RSV-LRI at Shizuoka Red Cross Hospital from the study time period. Of these, 20 patients (12.7%) were diagnosed with severe RSV-LRI. Subjects younger than 3 months of age had an odds ratio (OR) of 59.9 (95% confidence interval (CI) 14.7-244.0) for the dependent variable of severe RSV-LRI (P < 0.0001). Subjects with a history of congenital heart disease also had an OR of 99.2 (95% C1 8.5-1160.1) (P < 0.0005). Conclusions: Infants younger than 3 months without any underlying diseases may be at high risk for severe RSV-LRI. Respiratory syncytial virus prophylaxis is needed not only for high-risk patients, but for healthy early infants.
引用
收藏
页码:489 / 492
页数:4
相关论文
共 17 条
[1]  
ASAMURA S, 1997, J JPN PEDIAT SOC, V101, P1578
[2]   Prophylaxis against respiratory syncytial virus in premature infants [J].
Bont, L ;
van Vught, AJ ;
Kimpen, JLL .
LANCET, 1999, 354 (9183) :1003-1004
[3]  
COATES HV, 1964, POSTGRAD MED, V3, P460
[4]  
Englund JA, 1999, J PEDIATR-US, V135, pS38
[5]  
GLEZEN WP, 1977, PEDIATR RES, V11, P239
[6]   PROPHYLACTIC ADMINISTRATION OF RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN TO HIGH-RISK INFANTS AND YOUNG-CHILDREN [J].
GROOTHUIS, JR ;
SIMOES, EAF ;
LEVIN, MJ ;
HALL, CB ;
LONG, CE ;
RODRIGUEZ, WJ ;
ARROBIO, J ;
MEISSNER, HC ;
FULTON, DR ;
WELLIVER, RC ;
TRISTRAM, DA ;
SIBER, GR ;
PRINCE, GA ;
VANRADEN, M ;
HEMMING, VG .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (21) :1524-1530
[7]  
Halsey NA, 1998, PEDIATRICS, V102, P1211, DOI 10.1542/peds.102.5.1211
[8]   RISK-FACTORS FOR RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED LOWER RESPIRATORY ILLNESSES IN THE 1ST YEAR OF LIFE [J].
HOLBERG, CJ ;
WRIGHT, AL ;
MARTINEZ, FD ;
RAY, CG ;
TAUSSIG, LM ;
LEBOWITZ, MD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (11) :1135-1151
[9]   Severe respiratory syncytial virus disease in Alaska native children [J].
Karron, RA ;
Singleton, RJ ;
Bulkow, L ;
Parkinson, A ;
Kruse, D ;
DeSmet, I ;
Indorf, C ;
Petersen, KM ;
Leombruno, D ;
Hurlburt, D ;
Santosham, M ;
Harrison, LH .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01) :41-49
[10]  
KAWASAKI Y, 1999, J JPN PEDIAT SOC, V103, P1222